Zhejiang Conba Pharmaceutical Co.,Ltd.’s Net Profit Rose 141.3% in First Quarter of 2023

Zhejiang Conba Pharmaceutical Co.,Ltd. (浙江康恩贝制药股份有限公司) (600572.SH) reported a net profit of 324.9 million yuan in the first quarter of 2023, up 141.3% year-on-year.

Meanwhile, the company posted 2.1 billion yuan in revenue, up 25.3% year-on-year.

At the end of the reporting period, it had 11.8 billion yuan in total assets and 4.2 billion yuan in total liabilities, with a liability-to-asset ratio of 35.5%.